Inventor
TANAKA HIROKO
US65 patents
⚠️ This page may combine multiple inventors who share the name “TANAKA HIROKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
31 patentsUS10035768B2Jul 31, 2018
C5aR antagonists
CHEMOCENTRYX INC23 citations94
US9834545B2Dec 5, 2017
Modulators of chemokine receptors
CHEMOCENTRYX INC26 citations94
US9809581B2Nov 7, 2017
Inhibitors of CXCR2
CHEMOCENTRYX INC23 citations94
US9573897B2Feb 21, 2017
C5AR antagonists
CHEMOCENTRYX INC24 citations94
US8906938B2Dec 9, 2014
C5aR antagonists
CHEMOCENTRYX INC28 citations92
US9745268B2Aug 29, 2017
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC11 citations91
US10562896B2Feb 18, 2020
6-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC11 citations86
US11384079B2Jul 12, 2022
6-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC5 citations84
US10828285B2Nov 10, 2020
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC5 citations84
US10660897B2May 26, 2020
C5aR antagonists
CHEMOCENTRYX INC6 citations84
US10532982B2Jan 14, 2020
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC4 citations84
US10464934B2Nov 5, 2019
Substituted tetrahydropyrans as CCR2 modulators
CHEMOCENTRYX INC5 citations84
US10370363B2Aug 6, 2019
Inhibitors of CXCR2
CHEMOCENTRYX INC6 citations84
US10336736B2Jul 2, 2019
Modulators of chemokine receptors
CHEMOCENTRYX INC6 citations84
US10266492B2Apr 23, 2019
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC8 citations84
US9783540B2Oct 10, 2017
Substituted tetrahydropyrans as CCR2 modulators
CHEMOCENTRYX INC7 citations84
US9750722B2Sep 5, 2017
Diazole amides
CHEMOCENTRYX INC5 citations84
US9328116B2May 3, 2016
Diazole lactams
CHEMOCENTRYX INC4 citations84
US9169248B2Oct 27, 2015
Diazole amides
CHEMOCENTRYX INC6 citations84
US9340509B2May 17, 2016
CCR6 compounds
CHEMOCENTRYX INC4 citations82
US11478460B2Oct 25, 2022
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC3 citations73
US11434230B2Sep 6, 2022
2-oxindole compounds
CHEMOCENTRYX INC1 citations73
US11040960B2Jun 22, 2021
Inhibitors of CXCR2
CHEMOCENTRYX INC3 citations73
US10988464B2Apr 27, 2021
Modulators of chemokine receptors
CHEMOCENTRYX INC3 citations73
US10759789B2Sep 1, 2020
2-oxindole compounds
CHEMOCENTRYX INC2 citations73
US10744118B2Aug 18, 2020
Diazole lactams
CHEMOCENTRYX INC2 citations73
US10421748B2Sep 24, 2019
2-oxindole compounds
CHEMOCENTRYX INC3 citations73
US9795599B2Oct 24, 2017
CCR6 compounds
CHEMOCENTRYX INC2 citations72
US12268675B2Apr 8, 2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC0 citations63
US11773091B2Oct 3, 2023
6-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC0 citations63
US12139475B2Nov 12, 2024
2-oxindole compounds
CHEMOCENTRYX INC0 citations62
NURIX THERAPEUTICS INC
6 patentsUS11530229B2Dec 20, 2022
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
NURIX THERAPEUTICS INC12 citations84
US11464802B2Oct 11, 2022
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC14 citations84
US11401267B2Aug 2, 2022
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
NURIX THERAPEUTICS INC11 citations84
US11951133B2Apr 9, 2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC2 citations71
US12485144B2Dec 2, 2025
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
NURIX THERAPEUTICS INC1 citations62
US12234230B2Feb 25, 2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
NURIX THERAPEUTICS INC1 citations62
TEIJIN LTD
5 patentsUS6028208AFeb 22, 2000
Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
TEIJIN LTD22 citations90
US5990346ANov 23, 1999
Prostaglandins and processes for production thereof
TEIJIN LTD19 citations82
US5986112ANov 16, 1999
Vitamin D3 derivative and production process thereof
TEIJIN LTD8 citations73
US5719297AFeb 17, 1998
Vitamin D3 derivatives and production process thereof
TEIJIN LTD10 citations73
US6177586B1Jan 23, 2001
Vitamin D3 derivative and production process thereof
TEIJIN LTD10 citations70
FAN PINGCHEN
2 patentsMILLENNIUM PHARM INC
2 patentsSHARP KK
1 patentBIOGEN IDEC INC
1 patentTEIJIN INTELLECTUAL PROPERTY C
1 patentCHEN WEIRONG
1 patentShowing the top 50 of 65 patents by PatentIndex Score.